Pathology of Parkinson’s disease

Abstract

In Parkinson’s disease (PD), in addition to degeneration of the nigrostriatal dopaminergic pathway, a variety of neuronal systems are involved, causing multiple neuromediator dysfunctions that account for the complex patterns of functional deficits. Degeneration affects the dopaminergic mesocorticolimbic system, the noradrenergic locus ceruleus (oral parts) and motor vagal nucleus, the serotonergic raphe nuclei, the cholinergic nucleus basalis of Meynert, pedunculopontine nucleus pars compacta, Westphal-Edinger nucleus, and many peptidergic brainstem nuclei. Cell losses in subcortical projection nuclei range from 30 to 90% of controls; they are more severe in depressed and demented PD patients. Most of the lesions are region-specific, affecting not all neurons containing a specific transmitter or harboring Lewy bodies. In contrast to Alzheimer’s disease (AD), subcortical system lesions in Parkinson’s disease appear not to be related to cortical pathology, suggesting independent or concomitant degeneration. The pathogenesis of multiple-system changes contributing to chemical pathology and clinical course of Parkinson’s disease are unknown.

Arendt A., Bigl V., and Tennstedt A. (1985) Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical area in Alzheimer’s disease.Neuroscience14, 1–14.

Chan-Palay V. and Asan E. (1989a) Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression.J. Comp. Neurol.287, 357–372.

Chan-Palay V. and Asan E. (1989b) Alterations in catecholamine neurons of the locus coeruleus in senile dementia of Alzheimer type and in Parkinson’s disease with and without dementia and depression.J. Comp. Neurol.287, 373–392.

Gaspar P., Berger B., and Lesur A. (1987) Somatostatin 28 and neuropeptide Y innervation in the septal area and related cortical and subcortical structures of the human brain. Distribution, relationship and evidence for different coexistence.Neuroscience22, 49–73.

Gibb W. R. G., Terruli M., Lees A. J., Jenner P., and Marsden C. D. (1989b) The evolution of morphological changes in the nervous system of the common marmoset following the acute administration of MPTP.Movement Disord.4, 53–74.

Goto S., Hirano A., and Matsumoto S. (1990) Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison with those in Parkinson’s and Alzheimer’s diseases.Ann. Neurol.27, 520–527.

Mann D. M. A., Yates P. O., and Marcyniuk B. (1985b) Changes in Alzheimer’s disease in the magnocellular neurons of the supraoptic and paraventricular nuclei and their relationship to the noradrenergic deficit.Clin. Neuropathol.4, 127.